Market Cap | 85.87M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -108.17M | Forward P/E | -0.07 | EPS next Y | - | 50D Avg Chg | -12.00% |
Sales | 41.11M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -48.00% |
Dividend | N/A | Price/Book | 1.04 | EPS next 5Y | 59.20% | 52W High Chg | -94.00% |
Recommedations | 3.00 | Quick Ratio | 2.67 | Shares Outstanding | 20.76M | 52W Low Chg | 7.00% |
Insider Own | 5.43% | ROA | -60.08% | Shares Float | 19.64M | Beta | 1.48 |
Inst Own | 6.39% | ROE | -2,457.08% | Shares Shorted/Prior | 42.08K/12K | Price | 4.14 |
Gross Margin | 41.95% | Profit Margin | -263.14% | Avg. Volume | 23,029 | Target Price | - |
Oper. Margin | -206.47% | Earnings Date | Mar 21 | Volume | 12,391 | Change | -1.66% |
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. It markets and sells hearing aids. The company sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2014. Eargo, Inc. was incorporated in 2010 and is headquartered in San Jose, California.
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Brownie William | Chief Operating Offi.. Chief Operating Officer | Aug 16 | Sell | 1.3207 | 25,750 | 34,008 | 166,921 | 08/18/22 |
Wu David James | Director Director | Aug 11 | Sell | 0.95 | 10,120 | 9,614 | 1,542,259 | 08/15/22 |
Wu David James | Director Director | Oct 20 | Buy | 18 | 111,111 | 1,999,998 | 1,552,379 | 08/12/22 |
Richardson Nina | Director Director | Mar 14 | Sell | 3.52 | 3,886 | 13,679 | 03/16/22 |